Samuel Bates Martin, SVP and CFO at Celldex Therapeutics, Inc. (CLDX), sold 9,500 shares at $42.00 ($399K) on 2021-12-23, disclosed to the SEC on 2021-12-28.
Open-market sale of $399k CLDX by SVP and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CLDX | SELL | 2022-08-15 | $1.4M | — | Filing → |
| CLDX | SELL | 2021-11-17 | $828K | — | Filing → |
| CLDX | SELL | 2021-08-12 | $124K | — | Filing → |